Education
About Us
Working with TipRanks
Follow Us
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347
3347 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$25.05 - HK$58.80
Previous CloseN/A
Volume678.40K
Average Volume (3M)4.40M
Market Cap
€39.74B
Enterprise ValueHK$30.99B
Total Cash (Recent Filing)¥7.44B
Total Debt (Recent Filing)¥3.65B
Price to Earnings (P/E)59.8
Beta2.01
Next Earnings
Apr 29, 2025EPS Estimate
0.34Last Dividend Ex-Date
Jun 07, 2024Dividend Yield2.12%
Share Statistics
EPS (TTM)0.51
Shares Outstanding123,124,800
10 Day Avg. Volume4,198,354
30 Day Avg. Volume4,398,588
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$37.70Price Target Upside24.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Hangzhou Tigermed Consulting Co., Ltd. Class H News
PremiumCompany Announcements
Hangzhou Tigermed Announces Strategic Reallocation of H Shares Proceeds
PremiumCompany Announcements
Hangzhou Tigermed Proposes Amendments to Articles of Association
PremiumCompany Announcements
Hangzhou Tigermed Declares Final Dividend for 2024
PremiumCompany Announcements
Hangzhou Tigermed Reports Significant Profit Decline in 2024
PremiumCompany Announcements
Hangzhou Tigermed Consulting Schedules Board Meeting for Annual Results
PremiumCompany Announcements
Hangzhou Tigermed Projects Financial Decline for 2024PremiumCompany Announcements
Hangzhou Tigermed’s 2024 Q3 Report Highlights---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.97%
Mutual Funds
― Other Institutional Investors
90.97% Public Companies and
Individual Investors
3347 FAQ
What was Hangzhou Tigermed Consulting Co., Ltd. Class H’s price range in the past 12 months?
Hangzhou Tigermed Consulting Co., Ltd. Class H lowest stock price was HK$25.05 and its highest was HK$58.80 in the past 12 months.
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s market cap?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s market cap is €39.74B.
When is Hangzhou Tigermed Consulting Co., Ltd. Class H’s upcoming earnings report date?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s upcoming earnings report date is Apr 29, 2025 which is in 22 days.
How were Hangzhou Tigermed Consulting Co., Ltd. Class H’s earnings last quarter?
Hangzhou Tigermed Consulting Co., Ltd. Class H released its earnings results on Mar 27, 2025. The company reported -HK$0.503 earnings per share for the quarter, missing the consensus estimate of -HK$0.055 by -HK$0.448.
Is Hangzhou Tigermed Consulting Co., Ltd. Class H overvalued?
According to Wall Street analysts Hangzhou Tigermed Consulting Co., Ltd. Class H’s price is currently Undervalued.
Does Hangzhou Tigermed Consulting Co., Ltd. Class H pay dividends?
Hangzhou Tigermed Consulting Co., Ltd. Class H pays a Annually dividend of HK$0.623 which represents an annual dividend yield of 2.12%. See more information on Hangzhou Tigermed Consulting Co., Ltd. Class H dividends here
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate is 0.34.
How many shares outstanding does Hangzhou Tigermed Consulting Co., Ltd. Class H have?
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding.
What happened to Hangzhou Tigermed Consulting Co., Ltd. Class H’s price movement after its last earnings report?
Hangzhou Tigermed Consulting Co., Ltd. Class H reported an EPS of -HK$0.503 in its last earnings report, missing expectations of -HK$0.055. Following the earnings report the stock price went up 4.064%.
Which hedge fund is a major shareholder of Hangzhou Tigermed Consulting Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3347
---
Hangzhou Tigermed Consulting Co., Ltd. Class H Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$37.70 (24.22% Upside)
HK$37.70 (24.22% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.12%
12-Months-Change
Fundamentals
Return on Equity
1.87%
Trailing 12-Months
Asset Growth
0.15%
Trailing 12-Months
Company Description
Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. It is engaged in providing professional full clinical trial services. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
---
3347 Stock 12 Month Forecast
Average Price Target
HK$37.70
▲(24.22% Upside)
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
Livzon Pharmaceutical Group
―
Shanghai Fosun Pharmaceutical (Group) Co
―
Wuxi Biologics (Cayman)
―
Best Analysts Covering 3347
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+10.30%
reiterated a sell rating 7 days ago
Copying Yang Huang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.30% per trade.
---